- MSKCC’s Dr. Larry Norton was quoted in a U.S. News & World Report article about the resulting debate that occurred after a panel of experts writing in the July 29 online edition of the Journal of the American Medical Association expressed that widespread cancer screening programs turn up too many growths that would not progress to a lethal stage and are considered “indolent.”
- Visceral pleural invasion (VPI) significantly increases the risk for recurrence and reduces overall survival (OS) in patients with non-small-cell lung cancer (NSCLC), reported MSKCC’s Prasad Adusumilli and co-authors in a June 2013 article published in Chest.
- The RBC Decathlon benefiting MSKCC, visited the NASDAQ MarketSite in Times Square.
Author Archives: Mark
MSKCC in the News: July 12 – July 24
- Researchers from MSKCC recently discovered that the most frequently used cancer cell lines in ovarian cancer research are not suitable models of ovarian cancer.
- MSKCC’s Andrew Vickers was quoted in a Time article about a study that links omega-3 fatty acids to an elevated risk of prostate cancer.
- Researchers at MSKCC, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
MSKCC in the News: June 6 – July 11
- Dr. Mark Kris was interviewed on CBS This Morning about MSKCC’s collaboration with IBM’s Watson.
- MSKCC’s Dr. Arthur Brown will deliver the keynote address at the 2013 Medgate User Group Conference.
- Researchers at MSKCC, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
- MSKCC will purchase the former Lucent building on Red Hill Road for $14 million, according to a report in The Star-Ledger.